Key result
AF catheter ablation is linked to a ~3.5-point increase in eGFR despite arrhythmia recurrence.
Why the study?
Renal function in patients with recurrence of AF after catheter ablation had not been studied separately, despite known improvements after successful ablation.
Does catheter ablation improve renal function in patients with NVAF and mildly impaired renal function who experience AF recurrence?
Observational (n=132)
No
Does catheter ablation improve renal function in patients with NVAF and mildly impaired renal function who experience AF recurrence?
Catheter ablation may improve renal function in AF patients with mild renal impairment even if they experience arrhythmia recurrence, likely due to a reduction in overall AF burden.
Answers are grounded in this paper and cite their sources.
May support renal benefit from ablation despite recurrence in mild impairment; leaves open need for RCTs before any practice change.
Background . Impaired renal function and atrial fibrillation (AF) can form a vicious cycle. Although there have been reports on improved renal function in patients who undergo successful AF ablation, renal function in patients with recurrence of AF has not been studied separately. We explored the changes in renal function in recurrent AF patients after catheter ablation with mild renal dysfunction and the influencing factors. Methods . We retrospectively recruited nonvalvular AF (NVAF) patients with mildly impaired renal function admitted for catheter ablation and readmitted due to recurrence of AF. The estimated glomerular filtration rate (eGFR) was calculated before the index procedure and during readmission. △ eGFR was defined as the difference between eGFR readmission and eGFR baseline . The same calculation applied for △ CHA 2 DS 2 ‐VASc score. The primary endpoint was improved renal function (△eGFR >0) after AF catheter ablation in patients with atrial arrhythmia recurrence. Results . A total of 132 NVAF patients were included in this study. The mean eGFR at readmission was significantly increased compared with the eGFR at baseline before the index ablation procedure (81.5 ± 1.1 vs . 78.0 ± 0.7 ml/min/1.73 m 2 , P < 0.001). The multivariable Cox regression analysis showed that a lower △ CHA 2 DS 2 ‐VASc score (HR: 0.42, P = 0.003) and paroxysmal recurrent atrial arrhythmia (HR: 2.97, P = 0.001) were associated with better renal function. Conclusion . In NVAF patients with mildly impaired renal function, even those with recurrence after the initial catheter ablation, we observed improvements in renal function, which was associated with a lower △ CHA 2 DS 2 ‐VASc score and paroxysmal recurrent arrhythmia.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2022) conducted an observational in Nonvalvular atrial fibrillation with mildly impaired renal function (n=132). Catheter ablation vs. Baseline (pre-ablation) was evaluated on Mean estimated glomerular filtration rate (eGFR) at readmission compared to baseline (p=<0.001). In patients with nonvalvular atrial fibrillation and mild renal impairment, catheter ablation was associated with a significant increase in mean eGFR from 78.0 to 81.5 ml/min/1.73 m2 despite arrhythmia recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: